Publication | Open Access
Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
223
Citations
18
References
2022
Year
Covid-19 PandemicAntiviral TherapyPlacebo-controlled TrialMedicineIntramuscular AdministrationPhase 3Covid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1